Trulieve Cannabis (NYSE:TRLV – Get Free Report) and RYTHM (NASDAQ:RYM – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability.
Profitability
This table compares Trulieve Cannabis and RYTHM’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Trulieve Cannabis | -41.55% | -4.24% | -1.72% |
| RYTHM | -6.20% | -12.57% | -2.60% |
Analyst Ratings
This is a summary of recent ratings for Trulieve Cannabis and RYTHM, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Trulieve Cannabis | 1 | 1 | 1 | 0 | 2.00 |
| RYTHM | 1 | 0 | 0 | 0 | 1.00 |
Trulieve Cannabis currently has a consensus price target of $15.00, indicating a potential upside of 41.78%. Given Trulieve Cannabis’ stronger consensus rating and higher probable upside, analysts plainly believe Trulieve Cannabis is more favorable than RYTHM.
Valuation and Earnings
This table compares Trulieve Cannabis and RYTHM”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Trulieve Cannabis | $1.14 billion | 1.79 | -$116.38 million | $0.11 | 96.18 |
| RYTHM | $17.28 million | 2.15 | -$33.26 million | ($10.53) | -1.62 |
RYTHM has lower revenue, but higher earnings than Trulieve Cannabis. RYTHM is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
6.0% of RYTHM shares are held by institutional investors. 3.8% of Trulieve Cannabis shares are held by insiders. Comparatively, 3.5% of RYTHM shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Trulieve Cannabis beats RYTHM on 8 of the 12 factors compared between the two stocks.
About Trulieve Cannabis
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.
About RYTHM
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
